附属治疗设施
University of Iowa Hospitals & Clinics
200 Hawkins Drive
爱荷华州City, IA 52242
01.医生概述
Doctor Overview
Dr. Muhammad Furqan is an oncologist at the University of Iowa Hospitals & Clinics (UIHC). He has experience treating esophageal, lung and万博专业版癌症。
Furqan博士已经练习了十多年。他还是UIHC霍顿综合癌症中心临床研究服务的医学总监。这是唯一位于国家癌症研究所(NCI)指定的癌症中心爱荷华州。该中心还专门从事各种间皮瘤治疗,包括万博专业版extrapleural pneumonectomy。
In addition to practicing medicine, Dr. Furqan is actively involved in academia and research. He received his medical degree in Pakistan at Dow Medical College. He then studied in the United States at Seton Hall University and New York Medical College. Now, he is an associate professor of internal medicine-hematology, oncology, and blood and marrow transplantation.
2020年,Furqan博士获得了NCI的癌症临床研究者团队领导奖(CCITLA)。该奖项认可参加临床试验的医生的领导能力。他参与了clinical trials for mesotheliomaand lung cancer. Dr. Furqan has also published and co-authored dozens of articles in medical and scientific journals.
02.快速事实
医生快速事实
Main Specialty:医学肿瘤学
Other Interests & Specialties:血液和骨髓移植,食管癌,实验疗法,头颈癌,血液学,白血病,肺癌,淋巴瘤,间皮瘤,骨髓瘤和胰腺癌。万博专业版
认证,奖励和荣誉:美国内科医学委员会内科委员会,获得2020年癌症临床研究者团队领导奖(CCITLA)的获得者
Education & Experience:
- DOW医学院的医学学位
- 纽约医学院血液学研究奖学金
- Residency in Internal Medicine at Seton Hall University
03.出版物
出版物
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer。BMC癌。2021年7月; 21(1):808。doi:10.1186/s12885-021-08530-Z
The clinical significance of soluble PD-1 and PD-L1 in lung cancer。Critical Reviews in Oncology/Hematology。2019年11月; 143:148-152。doi:10.1016/j.critrevonc.2019.08.009
将高剂量的顺铂与顺铂的组合化学疗法进行比较。癌症医学。June 2019;8(6):2730-2739. doi:10.1002/cAM4.2139
O2Å和H 2 O 2介导的Fe代谢破坏引起NSCLC和GBM癌细胞对药理学抗坏血酸的敏感性。Cancer Cell。2017年8月; 32(2):268。doi:10.1016/j.ccell.2017.07.008
每天在有限阶段小细胞肺癌中每天的高剂量辐射(≥60Gy)治疗。肿瘤学杂志翻译研究。2016年11月; 2(1):108。
Germline mutations predisposing to non-small cell lung cancer。Familial Cancer。September 2015;14(3):463-469. doi:10.1007/s10689-015-9796-x